{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:16:56Z","timestamp":1795033016055,"version":"4.10.2"},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T00:00:00Z","timestamp":1111363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Approximately 6% of paediatric patients with precursor B\u2010cell acute lymphoblastic leukaemia (B\u2010ALL) harbour a rearrangement involving the gene regions of <jats:italic>PBX1<\/jats:italic> (1q23) and <jats:italic>E2A<\/jats:italic> (19p13.3) which is visualized cytogenetically either as a der(19)t(1;19)(q23;p13.3) or the less common balanced t(1;19)(q23;p13.3). Unfortunately, no commercial dual\u2010colour, double fusion fluorescence <jats:italic>in situ<\/jats:italic> hybridization (D\u2010FISH) strategies are available to detect this recurrent anomaly. Therefore, we have created a D\u2010FISH assay to detect these translocations and monitor minimal residual disease. This probe set was created using four bacterial artificial chromosomes (BACs) corresponding to the <jats:italic>PBX1<\/jats:italic> gene region at 1q23 and four BACs corresponding to the <jats:italic>E2A<\/jats:italic> gene region at 19p13.3. We analysed 30 negative bone marrow controls and 20 diagnostic and post\u2010treatment specimens from 13 paediatric B\u2010ALL patients with a cytogenetically defined 1;19 translocation. Once unblinded, the results demonstrated that our D\u2010FISH method effectively identified all diagnostic samples as abnormal and identified disease in four post\u2010treatment samples that were previously considered to be normal by conventional cytogenetic analysis. The development of this FISH strategy for the detection of der(19)t(1;19)(q23;p13.3) and t(1;19)(q23;p13.3) proved to be an effective technique, allowing both the detection of disease in diagnostic samples and in post\u2010treatment samples.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05415.x","type":"journal-article","created":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T14:25:52Z","timestamp":1111415152000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Interphase FISH to detect <i>PBX1<\/i>\/<i>E2A<\/i> fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"129","author":[{"given":"Brandon M.","family":"Shearer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather C.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Knudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,21]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V82.4.1086.1086","article-title":"Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukaemia for molecular analysis: a Pediatric Oncology Group study","volume":"82","author":"Borowitz M.J.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(03)00061-X"},{"key":"e_1_2_9_4_1","first-page":"821","article-title":"Expression of the E2A\u2010PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes","volume":"9","author":"Devaraj P.E.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-300-3:311"},{"key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/blood.V91.9.3357","article-title":"Highly sensitive fluorescence in situ hybridization method to detect double BCR\/ABL fusion and monitor response to therapy in chronic myeloid leukemia","volume":"91","author":"Dewald G.W.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402585"},{"key":"e_1_2_9_8_1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V87.4.1211.bloodjournal8741211","article-title":"Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis","volume":"87","author":"Hunger S.P.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood.V77.4.687.687","article-title":"The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias","volume":"77","author":"Hunger S.P.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_9_10_1","first-page":"671","article-title":"Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses","volume":"7","author":"Izraeli S.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_9_11_1","first-page":"111","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20133"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90658-2"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3581"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2002.03340.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2799390"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870020313"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90657-Z"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1627"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2601"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023001"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1182\/blood.V77.9.2016.2016","article-title":"New recurring chromosomal translocations in childhood acute lymphoblastic leukemia","volume":"77","author":"Raimondi S.C.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_9_23_1","first-page":"363","article-title":"Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia","volume":"6","author":"Secker\u2010Walker L.M.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19861115)58:10<2239::AID-CNCR2820581013>3.0.CO;2-I"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","article-title":"Large deletions at the t(9;22) breakpoint are common and may identify a poor\u2010prognosis subgroup of patients with chronic myeloid leukemia [see comment]","volume":"95","author":"Sinclair P.B.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(03)00202-4"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(88)90312-3"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08357.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.527"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.13.6061"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)09403-9"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222481199"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb03240.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05415.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05415.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:02:10Z","timestamp":1697439730000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05415.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,21]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05415.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05415.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,21]]},"assertion":[{"value":"2005-03-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}